{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1893,"total_is_capped":false,"direct_labels_cover":7,"predictions_cover":1893,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"b9b131b01a1f","filters":{"topic":"Hepatitis B Virus Studies"}},"results":[{"id":"W2000307707","doi":"10.1053/j.gastro.2011.12.061","title":"Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma","year":2012,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":3416,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Hepatocellular carcinoma; Epidemiology; Virology; Viral hepatitis; Medicine; Hepatitis virus; Hepatitis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08170312959118509,"gpt":0.3323137719421748,"spread":0.2506106423509897,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005613102,0.0005061328,0.004824209,0.0002986691,0.00004572646,8.232349e-7,0.0001444992,0.0004653201,0.0001097839],"category_scores_gemma":[0.0002668873,0.0004111334,0.0004961817,0.00007733572,0.0005799099,0.00003690265,0.0003138943,0.0005218109,0.00006209317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009624123,"about_ca_system_score_gemma":0.0000763354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009949834,"about_ca_topic_score_gemma":0.0002624358,"domain_scores_codex":[0.9965415,0.0007727108,0.00124386,0.0005026777,0.000114233,0.0008250224],"domain_scores_gemma":[0.9981942,0.0003165881,0.0006481208,0.0005144852,0.00007831635,0.00024831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004201789,0.00006529523,0.9006082,0.009685172,0.0004186034,0.0000664566,0.00003768415,5.533447e-9,4.105947e-7,0.0001111526,0.0002200598,0.08874499],"study_design_scores_gemma":[0.0009090683,0.002313017,0.2882617,0.002922044,0.004944377,0.002537766,0.000003382537,0.00001357265,9.555621e-7,0.00005635551,0.6977836,0.0002541989],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02658056,0.9718166,0.00009938618,0.00008979319,0.0003775077,0.0007675913,0.0001253637,0.00003255268,0.0001106226],"genre_scores_gemma":[0.03790924,0.9600083,0.0009454059,0.0003483209,0.0003241185,0.0001450011,0.0001527804,0.0000653526,0.0001014246],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6975635,"threshold_uncertainty_score":0.9998341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090738619","doi":"10.1016/s0140-6736(12)61425-1","title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1780,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Genentech; Gilead Sciences","keywords":"Medicine; Cirrhosis; Internal medicine; Gastroenterology; HBeAg; Fibrosis; Adverse effect; Liver biopsy; Hepatology; Hepatitis B; Biopsy; Hepatitis B virus; HBsAg; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.082798604222018,"gpt":0.3471109127141067,"spread":0.2643123084920886,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003063215,0.0002151285,0.0007919801,0.00004023854,0.0002337744,0.00002019605,0.0002220629,0.0000364483,0.00004173106],"category_scores_gemma":[0.00005349141,0.0001046177,0.00004717618,0.0001495968,0.00007930619,0.000132575,0.0001609964,0.00008400055,0.00002268951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002552472,"about_ca_system_score_gemma":0.0000685686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002852984,"about_ca_topic_score_gemma":0.004772847,"domain_scores_codex":[0.9987803,0.00007535906,0.0002420408,0.000219229,0.0002259054,0.0004572128],"domain_scores_gemma":[0.9989381,0.00007917136,0.0001579824,0.000663036,0.00008193484,0.0000798184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002051942,0.001099159,0.9827439,0.0001808638,0.0005901763,0.000007122017,0.00400535,5.405703e-7,0.003206269,0.00006387373,0.001113711,0.004937158],"study_design_scores_gemma":[0.03434389,0.008108499,0.9435251,0.0005791784,0.0006853673,0.00001406175,0.0003536468,0.00005027891,0.00719882,0.00003234923,0.004876488,0.0002323167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938431,0.001343387,0.0000152192,0.0008918404,0.0001341536,0.002650464,0.00008063599,0.00004534695,0.0009958091],"genre_scores_gemma":[0.9945324,0.001076606,0.0006941269,0.00007069534,0.000563303,0.0009033799,0.00001274471,0.00004213107,0.002104588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03921873,"threshold_uncertainty_score":0.4312878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108147025","doi":"10.1056/nejmoa051287","title":"Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sanofi Pasteur; New England Research Institutes; National Institutes of Health; American Association for the Study of Liver Diseases; Gilead Sciences; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Entecavir; Lamivudine; Medicine; HBeAg; Gastroenterology; Adefovir; Internal medicine; Hepatitis B; Telbivudine; Hepatitis B virus; Virology; Virus; HBsAg","retraction":null,"screen_n_in":null,"score":{"opus":0.01412396110701446,"gpt":0.2661991641540781,"spread":0.2520752030470637,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003466572,0.0002292861,0.0007328402,0.0002051042,0.0000892397,0.000005239564,0.0000964067,0.0000607832,0.0001499355],"category_scores_gemma":[0.0008340957,0.0001377101,0.00009154421,0.0002039904,0.0001858176,0.0001159652,0.00001925044,0.0002768626,0.000005374897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002855671,"about_ca_system_score_gemma":0.000273017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002174633,"about_ca_topic_score_gemma":0.005433649,"domain_scores_codex":[0.9981832,0.00004492402,0.000622038,0.000168561,0.0006713991,0.0003099061],"domain_scores_gemma":[0.9978182,0.0005786848,0.000450159,0.0001579844,0.0007790989,0.0002159275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008853395,0.0002855927,0.8800184,0.000132485,0.0005718375,0.0001758711,0.0005206099,0.00002558887,0.0002087134,0.0002404161,0.03891319,0.07005386],"study_design_scores_gemma":[0.2490268,0.02786621,0.6095542,0.00129231,0.0008198323,0.0001219836,0.00003099267,0.00004069083,0.0004294384,0.0004638206,0.1101459,0.0002078631],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867913,0.002196666,0.001705599,0.005491118,0.001144281,0.0006312645,0.00002572247,0.0000261704,0.001987939],"genre_scores_gemma":[0.9892873,0.0005778513,0.002131657,0.0002002952,0.007138098,0.000007993441,0.00003366293,0.00003001348,0.0005930922],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2704642,"threshold_uncertainty_score":0.5615654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059560167","doi":"10.1056/nejmoa0802878","title":"Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1179,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; University of Calgary; University of Toronto","funders":"Gilead Sciences; Canadian Institutes of Health Research; Canadian Liver Foundation; American Association for the Study of Liver Diseases; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Adefovir; HBeAg; Medicine; Gastroenterology; Hepatitis B virus; Internal medicine; Hepatitis B; Virology; HBsAg; Viral load; Reverse-transcriptase inhibitor; Lamivudine; Virus; Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.04905397422284643,"gpt":0.3052202999317802,"spread":0.2561663257089338,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006540424,0.0002834212,0.001000762,0.0002628855,0.0001999227,0.000006067323,0.0001692013,0.0001048248,0.0003046685],"category_scores_gemma":[0.001622804,0.0001862315,0.0001991571,0.0002438807,0.0003288552,0.000155657,0.00003701401,0.0004482838,0.00002426479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003044695,"about_ca_system_score_gemma":0.0006899118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001156688,"about_ca_topic_score_gemma":0.001530145,"domain_scores_codex":[0.9976694,0.00006866996,0.0008676329,0.0002191373,0.0007325275,0.0004426518],"domain_scores_gemma":[0.9977835,0.0005261182,0.0004450917,0.0002612899,0.0004778468,0.0005061024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01379729,0.0003747207,0.246407,0.0005153293,0.001722448,0.00315957,0.005734912,0.00004507631,0.01043992,0.0004345087,0.3800298,0.3373394],"study_design_scores_gemma":[0.1863722,0.02111117,0.1357478,0.001108139,0.0008934753,0.004142722,0.0000753107,0.0001738869,0.001187687,0.0003613367,0.6484858,0.0003404091],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.934719,0.02102095,0.003244707,0.03086943,0.004598981,0.0008490414,0.00002630295,0.00007033139,0.004601224],"genre_scores_gemma":[0.9682632,0.01361899,0.001085076,0.0006690547,0.01335088,0.00001261359,0.00001565,0.00005000877,0.002934539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3369989,"threshold_uncertainty_score":0.7594299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161280033","doi":"10.1056/nejmoa021812","title":"Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B","year":2003,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":999,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Adefovir; Medicine; Gastroenterology; HBeAg; Internal medicine; Placebo; Hepatitis B; Hepatitis B virus; Virology; HBsAg; Virus; Lamivudine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03047353680264755,"gpt":0.3029782780999622,"spread":0.2725047412973147,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006211419,0.000244542,0.0009617502,0.0001670918,0.0001292342,0.000005479937,0.000110836,0.00006946337,0.0003889931],"category_scores_gemma":[0.001442288,0.0001252647,0.0002268338,0.0002284191,0.0003048133,0.00007040686,0.000008096648,0.0001735646,0.000004108598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003015208,"about_ca_system_score_gemma":0.0005128667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004938493,"about_ca_topic_score_gemma":0.006560141,"domain_scores_codex":[0.9980521,0.0001260195,0.0008239264,0.0001573035,0.0005416283,0.000299007],"domain_scores_gemma":[0.9971787,0.001273625,0.0005513062,0.0002588231,0.0005010866,0.0002364662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001013189,0.0004779343,0.604856,0.0001671356,0.002065138,0.0002631024,0.009536278,0.00003962987,0.003166845,0.0009740841,0.01916071,0.35828],"study_design_scores_gemma":[0.08252766,0.03193846,0.2372552,0.001091216,0.001428516,0.000978791,0.000242245,0.0001318674,0.0136817,0.001147347,0.6293636,0.0002133235],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9255818,0.05150498,0.00544298,0.01211747,0.001866261,0.001260568,0.00004399955,0.0000197118,0.00216223],"genre_scores_gemma":[0.9101706,0.08422631,0.001285905,0.000287663,0.003125441,0.00001637954,0.000004267946,0.00002848545,0.000854931],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6102029,"threshold_uncertainty_score":0.7465556,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1964491003","doi":"10.1002/hep.23785","title":"Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡","year":2010,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":988,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Entecavir; Medicine; Gastroenterology; Internal medicine; Liver biopsy; Cirrhosis; HBeAg; Fibrosis; Biopsy; Lamivudine; Cohort; Nucleoside analogue; Hepatitis B virus; Immunology; HBsAg; Nucleoside; Virus; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01186840279274813,"gpt":0.2517910414192766,"spread":0.2399226386265285,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002872721,0.0001916252,0.000568248,0.0001372525,0.0000436433,0.000005878179,0.0001303349,0.0001727515,0.00003976808],"category_scores_gemma":[0.0001881747,0.0001204919,0.00004341856,0.0001824081,0.0004265095,0.00004880223,0.00006439602,0.0004142065,0.000003521915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009956927,"about_ca_system_score_gemma":0.00008123283,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005281133,"about_ca_topic_score_gemma":0.07375663,"domain_scores_codex":[0.9984461,0.0001301218,0.0005015173,0.0003585375,0.0002213391,0.0003423849],"domain_scores_gemma":[0.9991072,0.0002057364,0.0001859015,0.000360658,0.00009059595,0.00004984596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001208316,0.000409924,0.9842211,0.00004621097,0.00004120921,0.00007018077,0.0007182859,3.565006e-8,0.001608104,0.00006202549,0.0001986785,0.01141592],"study_design_scores_gemma":[0.007833687,0.002839339,0.9874264,0.0000782074,0.00002587969,0.00001548445,0.000008557359,0.00001761083,0.0007654552,0.00001767947,0.0008536226,0.0001180678],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969741,0.0004644292,0.000003741691,0.001262818,0.0001298981,0.0009415871,0.00003417742,0.00001601741,0.0001732281],"genre_scores_gemma":[0.9983011,0.000799888,0.0001448197,0.0005428806,0.00002820359,0.000115535,0.00003718103,0.00001224162,0.0000180924],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06847549,"threshold_uncertainty_score":0.9431449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058376942","doi":"10.1053/j.gastro.2006.09.020","title":"Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years","year":2006,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":882,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Adefovir; Gastroenterology; Internal medicine; Medicine; HBeAg; Hepatitis B virus; Hepatitis B; HBsAg; Immunology; Lamivudine; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01627792109879849,"gpt":0.2785087064634552,"spread":0.2622307853646567,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001059763,0.0002368451,0.0005187721,0.0001302994,0.00009364686,0.00001281769,0.0001131345,0.00008013621,0.00006835908],"category_scores_gemma":[0.0000494309,0.0001995827,0.0001325385,0.00008161646,0.0001629841,0.00005320352,0.00004248213,0.0001074609,0.00002679533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002810155,"about_ca_system_score_gemma":0.00006807876,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001064248,"about_ca_topic_score_gemma":0.04180098,"domain_scores_codex":[0.9984088,0.00004005785,0.0002928459,0.0004284177,0.0001448088,0.0006851033],"domain_scores_gemma":[0.9992331,0.0001075547,0.0001036136,0.0002698599,0.0001737475,0.0001121384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003769258,0.0001207146,0.9815335,0.00006301906,0.0002531484,0.00002674615,0.0002446184,0.00001160777,0.00108938,0.00006754001,0.009927718,0.0028928],"study_design_scores_gemma":[0.008301264,0.0145703,0.9708897,0.00007868727,0.00008443336,0.0000602697,0.00001234891,0.00003845114,0.001206776,0.00006906464,0.004567586,0.0001210655],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792777,0.000169037,0.01570825,0.001949202,0.0002890565,0.002255661,0.0001860533,0.0000768545,0.00008823055],"genre_scores_gemma":[0.9904379,0.0001150598,0.003840664,0.002358475,0.0006108504,0.0013994,0.00009924289,0.00006383291,0.001074566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04073673,"threshold_uncertainty_score":0.9756836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051173965","doi":"10.1126/science.1243462","title":"Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA","year":2014,"lang":"en","type":"article","venue":"Science","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":874,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institutes of Health; Partenariat Canadien Contre Le Cancer; Deutsche Forschungsgemeinschaft","keywords":"cccDNA; Hepatitis B virus; Lymphotoxin; Virology; Cytidine deaminase; Cytidine; Biology; Hepatitis B virus PRE beta; DNA; Virus; Hepatitis B virus DNA polymerase; Receptor; Enzyme; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02013978852024207,"gpt":0.2611237577242022,"spread":0.2409839692039601,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004829731,0.00007066906,0.0001641929,0.0001198379,0.0001490049,0.00001839353,0.00009454001,0.00002277538,0.00006350246],"category_scores_gemma":[0.0002064228,0.00006100444,0.00001986094,0.0003681257,0.0007163798,0.0001566681,0.0000749997,0.00005734589,0.00006202216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004347005,"about_ca_system_score_gemma":0.00004355657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009321515,"about_ca_topic_score_gemma":0.0004333724,"domain_scores_codex":[0.9990627,0.00001479205,0.0001568805,0.0002307647,0.0003585325,0.0001762978],"domain_scores_gemma":[0.999481,0.00002828894,0.00005953526,0.0002205617,0.000116353,0.00009432306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001153282,0.0000520527,0.5985626,0.00003990621,0.00000544778,0.000003814855,0.0005014213,4.071231e-7,0.3543378,0.003749168,0.000649258,0.04208657],"study_design_scores_gemma":[0.000258371,0.0002197084,0.9477314,0.00006160021,0.00000940896,0.00001344418,0.00001435301,0.001090196,0.03953028,0.0002222171,0.01077013,0.00007885147],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928825,0.0002027872,0.0001870583,0.0003340306,0.0001276151,0.000129891,0.000003510974,0.00002929811,0.006103233],"genre_scores_gemma":[0.9957996,0.001066903,0.002759916,0.0002116652,0.00004087656,0.000002660257,7.714075e-7,0.000007409004,0.0001101844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3491689,"threshold_uncertainty_score":0.2639531,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080222370","doi":"10.1016/j.jhep.2008.07.014","title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","year":2008,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":823,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Occult; Hepatitis B virus; Medicine; Virology; Hepatitis B; Viral infection; Immunology; Clinical significance; Virus; Internal medicine; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05275099865941291,"gpt":0.3496385023404673,"spread":0.2968875036810544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002779086,0.000162433,0.0005288878,0.0001119583,0.000265986,0.000007695548,0.0001011002,0.0001012621,0.0001721224],"category_scores_gemma":[0.0007031836,0.0001026743,0.0001594819,0.0001257518,0.0001501856,0.0001402648,0.00004839776,0.0003888765,0.00009125815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001944944,"about_ca_system_score_gemma":0.0001383663,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02768927,"about_ca_topic_score_gemma":0.00811612,"domain_scores_codex":[0.9983253,0.0002086284,0.0006618965,0.0001458522,0.0004006579,0.0002576518],"domain_scores_gemma":[0.9985927,0.0003616281,0.000469274,0.0001919445,0.0002855426,0.00009888048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002261102,0.0001560498,0.956655,0.000005325305,0.0002480719,0.0007227806,0.001543665,0.000004580299,0.002185792,0.00001079236,0.03558689,0.002654989],"study_design_scores_gemma":[0.002052361,0.001687112,0.8920919,0.0002363275,0.0001373233,0.002038582,0.00006840129,0.00009936748,0.01342007,0.0001530634,0.08784306,0.000172478],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937357,0.001166531,0.0001317657,0.002594587,0.0009184032,0.0001448807,0.0000116784,0.00001989143,0.001276569],"genre_scores_gemma":[0.9794194,0.01569897,0.0005726031,0.003657688,0.000546289,0.000008298446,0.000004809098,0.00001937065,0.00007255752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0645631,"threshold_uncertainty_score":0.9787855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2481374159","doi":"10.1038/nrdp.2018.35","title":"Hepatitis B virus infection","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":814,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatitis B virus; Immunology; Virus; Virology; Hepatitis B; Population; Viral load; Cirrhosis; Viral replication; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05220310407867247,"gpt":0.3948429274191597,"spread":0.3426398233404873,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005794772,0.00100557,0.004349432,0.0004104735,0.0002013335,0.00004322612,0.0002348729,0.0009928833,0.0006115224],"category_scores_gemma":[0.002230772,0.0007212682,0.002416037,0.0009199309,0.0002199752,0.0001254372,0.0001933174,0.001843685,0.004390242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007130913,"about_ca_system_score_gemma":0.0007558148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009505445,"about_ca_topic_score_gemma":0.0008055174,"domain_scores_codex":[0.9959471,0.0005588008,0.001299589,0.001024967,0.0005975355,0.0005719844],"domain_scores_gemma":[0.996803,0.000121609,0.0008110999,0.001253189,0.0002520215,0.0007590139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001441999,0.000125582,0.001358384,0.07044991,0.0005093676,0.00008241827,0.00001046398,3.01112e-9,9.599547e-8,0.00003204104,0.0837075,0.8437098],"study_design_scores_gemma":[0.0001650875,0.00007988796,0.001054212,0.06068332,0.009451739,0.0000357011,1.025768e-7,5.036204e-7,3.870744e-7,0.00001434538,0.9279485,0.0005662552],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004856843,0.9906909,0.00001023541,0.00005788291,0.001441786,0.004729612,0.0002186208,0.0002138158,0.002632298],"genre_scores_gemma":[0.000001588797,0.9938698,0.0004437852,0.0009497619,0.001704836,0.0009074676,0.001008838,0.0001702453,0.000943669],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.844241,"threshold_uncertainty_score":0.9995238,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283217337","doi":"10.1016/s2468-1253(22)00124-8","title":"Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019","year":2022,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":797,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Research Management Centre, International Islamic University Malaysia; Sistema Nacional de Investigadores; Centre for Heart Rhythm Disorders, University of Adelaide; National Health and Medical Research Council; Medical Research Council; School of Public Health and Family Medicine, University of Cape Town; University of Texas Health Science Center at San Antonio; Samsung; Dilla University; Pirogov Russian National Research Medical University; Universitas Ahmad Dahlan; Moscow Institute of Physics and Technology; Universitas Padjadjaran; Imam Abdulrahman Bin Faisal University; Kurdistan University Of Medical Sciences; University of Colombo; International Centre for Diarrhoeal Disease Research, Bangladesh; Xiamen University; Division of Mathematical Sciences; Universitas Airlangga; Golestan University of Medical Sciences; National Institute for Research in Tuberculosis; Southeast University; Alfaisal University; University of Gondar; University of Health and Allied Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Universitas Muhammadiyah Surakarta; Rajshahi University; University of Sulaimani; Instituto Politécnico do Porto; Semnan University; Secretaría Nacional de Ciencia, Tecnología e Innovación; Technische Universität Berlin; Universidade do Porto; Student Research Committee, Tabriz University of Medical Sciences; Peking Union Medical College; Bahir Dar University; Debre Tabor University; Università di Bologna; Shahid Beheshti University of Medical Sciences; Directorate for Biological Sciences; Göteborgs Universitet; Universidade de São Paulo; Qazvin University of Medical Sciences; Universitair Medisch Centrum Groningen; Guilan University of Medical Sciences; Kermanshah University of Medical Sciences; Universitas Syiah Kuala; Imperial College London; Shiraz University; Harvard University; Jimma University; Ministerio de Ciencia, Innovación y Universidades; Flinders University; Universiteit Utrecht; Nankai University; National Institutes of Health; University of Veterinary and Animal Sciences; Chinese University of Hong Kong; Haramaya University; Ain Shams University; Shiraz University of Medical Sciences; King Abdulaziz University; Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii; University of Oxford; Amirkabir University of Technology; King Abdullah University of Science and Technology; Eastern Virginia Medical School; Isfahan University of Medical Sciences; Islamic Azad University; Oxford University Hospitals NHS Foundation Trust; Gachon University; Ewha Womans University; Kyung Hee University; Yonsei University; Sharif University of Technology; Kuwait University; James Cook University; Curtin University of Technology; University of South Australia; Tabriz University of Medical Sciences; University of Cape Town; National Authority for Scientific Research and Innovation; Khalifa University of Science, Technology and Research; Ajman University; Universitas Indonesia; University of Technology Sydney; Birjand University of Medical Sciences; Gastrointestinal and Liver Diseases Research Center; Case Western Reserve University; University of Sydney; Charles Sturt University; Wuhan University; Rijksuniversiteit Groningen; Taipei Medical University; Cleveland Clinic; University College Cork; Amity University; Universitatea din București; La Trobe University; Fogarty International Center; COMSATS Institute of Information Technology; National University of Singapore; Generalitat de Catalunya; Stanford Cardiovascular Institute, School of Medicine, Stanford University; Frankfurt University of Applied Sciences; Macquarie University; Jordan University of Science and Technology; Hamad Bin Khalifa University; Division of Human Resource Development; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Neyshabur University of Medical Sciences; National Center of Neurology and Psychiatry; Mashhad University of Medical Sciences; Tribhuvan University; South African Medical Research Council; Kasturba Medical College, Manipal; Public Health England; Tehran University of Medical Sciences and Health Services; Fundação para a Ciência e a Tecnologia; Aksum University; Allos Therapeutics; Debre Markos University; South Eastern Sydney Local Health District; University of Dhaka; Wollega University; Social Science Research Council; College of Science and Engineering, University of Minnesota; Johns Hopkins University; Wellcome Trust; Institute of Infection and Immunity; Trường Đại học Duy Tân; Addis Ababa University; Università degli Studi di Firenze; Bill and Melinda Gates Foundation; Arak University of Medical Sciences; Università degli Studi di Milano; Iran University of Medical Sciences; University College London; Süleyman Demirel Üniversitesi; Deakin University; Helsingin Yliopisto; Madda Walabu University; Centres de Recerca de Catalunya; U.S. Department of Veterans Affairs; Jazan University; University of Tabriz; Ahmadu Bello University; United Arab Emirates University; Autoritatea Natională pentru Cercetare Stiintifică; Emory University; National Research University Higher School of Economics; Istituto Superiore di Sanità; McMaster University; Secretaria Nacional de Ciencia y Tecnología; University of South Carolina; Hamad Medical Corporation; Universidad de Antioquia; Mazandaran University of Medical Sciences; Università degli Studi di Napoli Federico II; New Mexico State University; Moffitt Cancer Center; Bournemouth University; University of Science and Technology of China; Georgetown University; Banaras Hindu University; United Nations Population Fund; University of Peshawar; Queensland University of Technology; Jahrom University of Medical Sciences; London South Bank University; Florida International University; University of Rochester","keywords":"Medicine; Viral hepatitis; Hepatitis B; Population; Hepatitis C; Global health; Liver disease; Hepatitis B virus; Cirrhosis; Liver cancer; Disease burden; Internal medicine; Environmental health; Cancer; Public health; Immunology; Pathology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.02812699209603827,"gpt":0.3040902406220946,"spread":0.2759632485260564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001176209,0.0003135786,0.001957942,0.0001832737,0.0003805296,0.00001053448,0.0006034072,0.00007202211,0.00006294309],"category_scores_gemma":[0.0003308517,0.0002182103,0.0003944396,0.0006123401,0.0007686392,0.00004198733,0.0005683339,0.0002217266,0.000003567493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003029056,"about_ca_system_score_gemma":0.000211093,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01135368,"about_ca_topic_score_gemma":0.01374159,"domain_scores_codex":[0.9960909,0.001031409,0.001023623,0.0005573055,0.0007009829,0.0005957783],"domain_scores_gemma":[0.9971523,0.000734738,0.0007403473,0.0008043831,0.0004377674,0.0001304831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002477002,0.0003188024,0.9757734,0.0007691052,0.005762942,0.00003430531,0.0005696906,0.0008934935,0.000007451888,0.0006478015,0.01272301,0.00002298216],"study_design_scores_gemma":[0.004626377,0.002891929,0.9698997,0.0001145295,0.006865347,0.0002745781,0.001053417,0.01225005,4.047764e-7,0.0008310944,0.001052367,0.0001401707],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773699,0.003212266,0.001114841,0.01341156,0.0003110377,0.002571822,0.001927916,0.00003728682,0.00004333998],"genre_scores_gemma":[0.9962863,0.0003923758,0.0001465786,0.001736787,0.0002229494,0.001026736,0.0001101167,0.00001776126,0.00006041455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01891635,"threshold_uncertainty_score":0.9952298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166826446","doi":"10.1053/gast.2001.24839","title":"Management of hepatitis B: 2000—Summary of a workshop","year":2001,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":786,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Virology; General surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.04240289298851569,"gpt":0.3281309429292618,"spread":0.2857280499407461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001882534,0.000405196,0.003320455,0.0003583132,0.00002130955,0.000001958365,0.0002409616,0.0002398707,0.0003063507],"category_scores_gemma":[0.0000305483,0.0003468428,0.0006322552,0.0002893164,0.0002675799,0.00002259491,0.000318293,0.0003274955,0.00004694713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000148353,"about_ca_system_score_gemma":0.00007571957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002256299,"about_ca_topic_score_gemma":0.0004004453,"domain_scores_codex":[0.997447,0.0001810044,0.001197791,0.0004114132,0.0002676068,0.0004951597],"domain_scores_gemma":[0.9984211,0.0000758304,0.0006607495,0.000639813,0.0001026196,0.00009984872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001574771,0.0003367233,0.03533934,0.04332475,0.003119683,0.0007848476,0.00005629665,2.981776e-7,2.032982e-7,0.00005206948,0.008526819,0.9083015],"study_design_scores_gemma":[0.0008026001,0.0008678078,0.003732779,0.03114248,0.003480384,0.000345076,0.00001243879,0.000001157639,3.549605e-7,0.00001274689,0.9594842,0.0001179432],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004054468,0.9940292,0.000179603,0.00008402212,0.0003017576,0.0009710568,0.0001211329,0.00003039656,0.003877365],"genre_scores_gemma":[0.0001398719,0.9955059,0.001775143,0.0001050028,0.000101079,0.0001570028,0.0001323714,0.00005832232,0.002025364],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9509574,"threshold_uncertainty_score":0.9998984,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2027543203","doi":"10.1056/nejmoa066422","title":"Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":775,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"New England Research Institutes; Gilead Sciences; Vertex Pharmaceuticals; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Lamivudine; Telbivudine; Chronic hepatitis; Hepatitis B; Internal medicine; Virology; Gastroenterology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01586055320689977,"gpt":0.2747550784136844,"spread":0.2588945252067846,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00104689,0.0002110796,0.000743309,0.0004563991,0.00004047022,0.000004080703,0.0001032097,0.00006871387,0.0003024159],"category_scores_gemma":[0.0008638769,0.0001285393,0.00005042236,0.0004447955,0.0001518535,0.0001141688,0.00002603255,0.0004924983,0.00000942847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003954278,"about_ca_system_score_gemma":0.0002487435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001683986,"about_ca_topic_score_gemma":0.01669644,"domain_scores_codex":[0.9978171,0.00003981564,0.0007648498,0.0001547298,0.0008416657,0.0003818684],"domain_scores_gemma":[0.9983951,0.0003303013,0.0003354349,0.0001807423,0.0004077276,0.0003506392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006262153,0.0001293414,0.8838402,0.00004092629,0.0001623026,0.0007010056,0.0004615315,0.000006946034,0.000117978,0.0000423801,0.003486603,0.1047486],"study_design_scores_gemma":[0.1437218,0.01100361,0.8163081,0.0009117086,0.0001704504,0.0001238617,0.00001961402,0.000005773923,0.0001361621,0.00002783792,0.02746284,0.0001082272],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900289,0.001947746,0.0004141706,0.003775252,0.0008698932,0.0002351546,0.000002057364,0.00001512053,0.002711751],"genre_scores_gemma":[0.9938778,0.0009412268,0.0007590404,0.0002960261,0.003839395,8.174633e-7,0.000009698741,0.00002769205,0.0002482834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1374597,"threshold_uncertainty_score":0.9317004,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076506726","doi":"10.1053/j.gastro.2003.09.033","title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","year":2003,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":767,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases","keywords":"Lamivudine; Medicine; Gastroenterology; Decompensation; HBeAg; Internal medicine; Adverse effect; Hepatitis B; Chronic hepatitis; Hepatitis B virus; Virology; HBsAg; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.008841963964688239,"gpt":0.2379804515862287,"spread":0.2291384876215404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006135533,0.000173529,0.0005133174,0.0001259611,0.00002459083,0.000001566235,0.00004249578,0.00004980707,0.0001964504],"category_scores_gemma":[0.00003099812,0.0001318614,0.00005301391,0.00009094487,0.0001379536,0.000034026,0.00002232237,0.00008370561,0.00001526843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003999695,"about_ca_system_score_gemma":0.00005949686,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006585183,"about_ca_topic_score_gemma":0.0403953,"domain_scores_codex":[0.998815,0.00009557269,0.0003282027,0.0002391285,0.0001366446,0.0003854641],"domain_scores_gemma":[0.9994856,0.00002165811,0.0001013212,0.0002486219,0.00007543292,0.00006743367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001128538,0.000617615,0.996785,0.00004201273,0.0001684621,0.00005581899,0.00009980119,0.000006885994,0.00003629085,0.00002949979,0.0000318839,0.0009982032],"study_design_scores_gemma":[0.009391055,0.01020413,0.9798096,0.00008281352,0.0000681453,0.00001858347,0.000001533578,0.000003068616,0.0001943996,0.000003044736,0.0001733775,0.00005028143],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985704,0.0001049393,0.0001473894,0.0001619107,0.00008604392,0.0005296736,0.00002895955,0.00001681536,0.0003538488],"genre_scores_gemma":[0.9990066,0.0002820117,0.0003206561,0.0001430605,0.00002215471,0.0000494053,0.00005130495,0.00001914673,0.000105684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03973678,"threshold_uncertainty_score":0.977115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093604720","doi":"10.1053/gast.2003.50013","title":"Histological outcome during long-term lamivudine therapy","year":2003,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":728,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Massachusetts General Hospital; GlaxoSmithKline","keywords":"Lamivudine; Medicine; Cirrhosis; Gastroenterology; Internal medicine; Fibrosis; Chronic hepatitis; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.04388510940682998,"gpt":0.3046885553338609,"spread":0.2608034459270309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001246186,0.0001846611,0.0004807574,0.00009148,0.00008576969,0.000004859782,0.00007854438,0.00008855133,0.0005555906],"category_scores_gemma":[0.000140994,0.0001457497,0.0001170517,0.00005496321,0.0001738876,0.00003102817,0.00004466498,0.0002294274,0.000140451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009778045,"about_ca_system_score_gemma":0.00001214388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001677176,"about_ca_topic_score_gemma":0.0001865379,"domain_scores_codex":[0.9985893,0.0001215329,0.0003282081,0.0003036879,0.0001312407,0.0005260425],"domain_scores_gemma":[0.9994596,0.00002435157,0.00007513613,0.0002740356,0.0000502167,0.0001166228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004192934,0.0001766105,0.9950799,0.00002067977,0.0001046033,0.0003021863,0.00005356824,4.38849e-7,0.003237143,0.00008631338,0.0003564384,0.0001627729],"study_design_scores_gemma":[0.002988317,0.0009906839,0.993616,0.00001004221,0.00002907431,0.0008171765,0.000004196372,8.97847e-7,0.0004418107,0.00001750853,0.001022133,0.00006209425],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959121,0.000386596,0.00023075,0.001158234,0.0003228441,0.0002323066,0.000003262249,0.0001052068,0.001648664],"genre_scores_gemma":[0.9960486,0.0002668553,0.0004837896,0.002264007,0.00008652476,0.00004050765,0.000006705038,0.00002097498,0.0007820402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002795333,"threshold_uncertainty_score":0.6083327,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2042565956","doi":"10.1002/hep.23327","title":"Entecavir Treatment for Up to 5 Years in Patients With Hepatitis B E Antigen–Positive Chronic Hepatitis B","year":2010,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":586,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Chronic hepatitis; Hepatitis B; Antigen; Virology; Internal medicine; Gastroenterology; Immunology; Lamivudine; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01139755731832995,"gpt":0.2757998071140779,"spread":0.264402249795748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008401921,0.00030537,0.0007244656,0.0002866952,0.00009614491,0.00001270454,0.0001046036,0.000188284,0.0001963395],"category_scores_gemma":[0.0001330821,0.0002662223,0.00010295,0.0002673851,0.0001558272,0.00007475762,0.00006133469,0.0002124914,0.0001588011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005178339,"about_ca_system_score_gemma":0.0002796338,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01726428,"about_ca_topic_score_gemma":0.2478303,"domain_scores_codex":[0.9981403,0.00005176444,0.0003753698,0.0005604802,0.0002151441,0.0006569873],"domain_scores_gemma":[0.9989274,0.0001322432,0.00009334843,0.000415301,0.0002186051,0.000213157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004643023,0.0003035537,0.9763776,0.00002630209,0.00014381,0.0001128259,0.0008787461,6.398627e-7,0.0002708842,0.0002484016,0.0009278163,0.02024511],"study_design_scores_gemma":[0.005221217,0.005067558,0.9601803,0.00007641709,0.00007052203,0.00002292569,0.000007391381,0.0001073115,0.001695508,0.00003038172,0.02725563,0.0002648127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953701,0.00009595971,0.0001853578,0.0006905773,0.0006857976,0.00225833,0.0002427169,0.00007281457,0.0003983394],"genre_scores_gemma":[0.9958923,0.0003276624,0.001728743,0.0006684841,0.0001387288,0.000679709,0.0001725991,0.00005312803,0.0003386599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2305661,"threshold_uncertainty_score":0.999979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062680879","doi":"10.1053/j.gastro.2008.10.026","title":"2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B","year":2008,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":565,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Telbivudine; Lamivudine; Medicine; Gastroenterology; Internal medicine; HBeAg; Chronic hepatitis; Hepatitis B; Viremia; Hepatitis B virus; Immunology; HBsAg; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01336883761041295,"gpt":0.2430121391078703,"spread":0.2296433014974573,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001366964,0.0002821682,0.0007348756,0.0002595673,0.00008878551,0.000006072256,0.0001368081,0.0001000849,0.0002075024],"category_scores_gemma":[0.0002282885,0.0002355758,0.00007836105,0.0002797221,0.0001970181,0.00007959221,0.0001442548,0.000257376,0.0002083292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003854693,"about_ca_system_score_gemma":0.00009599595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0020458,"about_ca_topic_score_gemma":0.01756052,"domain_scores_codex":[0.9976527,0.0000909111,0.0005926497,0.0005522217,0.0003586698,0.000752826],"domain_scores_gemma":[0.9990446,0.00003327381,0.00009756198,0.0004451397,0.0001750307,0.0002043958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08150022,0.0003833662,0.9065745,0.00001687362,0.00009008472,0.0001575389,0.0004036858,0.0000038997,0.00003445009,0.000002766858,0.01061724,0.0002153026],"study_design_scores_gemma":[0.1032606,0.02048182,0.871246,0.00007965021,0.00003650528,0.00003866819,0.000005691599,0.00000787812,0.00005948569,0.000001679963,0.004673732,0.0001082857],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936348,0.00003342175,0.00004638427,0.004120374,0.0002838719,0.001286852,0.0002001997,0.00006585163,0.000328214],"genre_scores_gemma":[0.9949539,0.0001585882,0.001092152,0.002875865,0.0003499599,0.0001376592,0.00009591669,0.00004075064,0.0002952153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03532855,"threshold_uncertainty_score":0.9799184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135386419","doi":"10.1016/j.cgh.2008.08.021","title":"A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update","year":2008,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Gilead Sciences; Valeant Pharmaceuticals International; Schering-Plough; GlaxoSmithKline; Novartis; Pfizer","keywords":"Entecavir; Medicine; Telbivudine; Adefovir; Lamivudine; Algorithm; Intensive care medicine; Pegylated interferon; Hepatitis B virus; Hepatitis B; Internal medicine; Chronic hepatitis; Immunology; Virus; Ribavirin","retraction":null,"screen_n_in":null,"score":{"opus":0.0820841192138379,"gpt":0.3993011768067398,"spread":0.3172170575929019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000474973,0.0004317343,0.002519578,0.0002295647,0.0001654315,0.000005333828,0.0001944659,0.0004269386,0.00002193039],"category_scores_gemma":[0.0000443165,0.0002298847,0.0006019485,0.0002224808,0.00109723,0.00001966175,0.00013297,0.0005642955,0.00001586381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001719822,"about_ca_system_score_gemma":0.0001276595,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004589872,"about_ca_topic_score_gemma":0.02160612,"domain_scores_codex":[0.9963878,0.0009413344,0.001500789,0.0005349941,0.0001114337,0.0005235799],"domain_scores_gemma":[0.9974135,0.001384364,0.0005367293,0.0005134799,0.00007909875,0.00007279474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002188088,0.0007926409,0.1798994,0.002160368,0.002734216,0.0003580621,0.00008052342,0.000001078655,2.407119e-9,0.00006947314,0.002085202,0.8116003],"study_design_scores_gemma":[0.002847809,0.006702146,0.02401259,0.001006934,0.00300257,0.001213612,0.00000887299,0.001054811,4.044253e-8,0.00003604256,0.9600036,0.0001110129],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01100198,0.9815506,0.002393189,0.001015813,0.000582725,0.003177069,0.0002350735,0.00002679958,0.00001670562],"genre_scores_gemma":[0.0003478655,0.9959134,0.000472414,0.001161455,0.0001859653,0.001375813,0.0004759856,0.0000323203,0.00003478199],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9579183,"threshold_uncertainty_score":0.996247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2120667564","doi":"10.1053/j.gastro.2003.10.051","title":"Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).","year":2003,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":554,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Adefovir; Lamivudine; Virology; Hepatitis B virus; Hepatitis B; Chronic hepatitis; HBeAg; Gastroenterology; Medicine; Internal medicine; Virus; HBsAg","retraction":null,"screen_n_in":null,"score":{"opus":0.008087156946633995,"gpt":0.221100717287068,"spread":0.213013560340434,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.002501071,0.002282534,0.004257249,0.0006990367,0.001205088,0.0001960209,0.002056066,0.001426529,0.00115425],"category_scores_gemma":[0.0007048139,0.002051117,0.0003643809,0.001057473,0.004499943,0.001978263,0.00162217,0.002497941,0.000001676904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00197386,"about_ca_system_score_gemma":0.004185624,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7304344,"about_ca_topic_score_gemma":0.9780214,"domain_scores_codex":[0.9839419,0.001503621,0.003284805,0.003482505,0.005218347,0.002568807],"domain_scores_gemma":[0.992199,0.0009053048,0.002599462,0.001277849,0.0008962482,0.002122134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003745075,0.003501605,0.9484109,0.0006098088,0.0016614,0.002855024,0.003225609,0.0000176746,0.000009292608,0.00006985981,0.03431765,0.001576103],"study_design_scores_gemma":[0.06277988,0.01057748,0.8706117,0.003331377,0.0005620591,0.0003983659,0.004332308,0.0007953639,0.000009695872,0.00003355274,0.04467792,0.001890258],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9600236,0.02004536,0.0005362867,0.006191881,0.002932603,0.004448296,0.005617404,0.00009990689,0.0001046705],"genre_scores_gemma":[0.9810694,0.01415242,0.0009124862,0.0006369308,0.000523157,0.00005099116,0.001827083,0.0002032417,0.0006242361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.247587,"threshold_uncertainty_score":0.9998698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2938429240","doi":"10.1016/j.jhep.2019.03.034","title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","year":2019,"lang":"en","type":"review","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":549,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Southern Medical University; Institut National de la Santé et de la Recherche Médicale; National Taiwan University; Institut National de la Transfusion Sanguine; Università degli Studi di Messina; Medizinischen Hochschule Hannover; Università degli Studi di Parma; Universidad Internacional de La Rioja; World Health Organization; Università degli Studi di Pavia; Universitätsklinikum Hamburg-Eppendorf; National Institutes of Health; Regione Campania; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","keywords":"Occult; Virology; Hepatitis B virus; Medicine; Virus; Immunology; Biology; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1269912861693147,"gpt":0.5198938413179149,"spread":0.3929025551486003,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008511299,0.0003070646,0.003998096,0.0003473389,0.00003471272,0.000003165113,0.000167867,0.0004752232,0.00007934267],"category_scores_gemma":[0.0008821815,0.0001597063,0.001305038,0.0002014043,0.0003840957,0.00005477556,0.0001467817,0.0008235049,0.00001921208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001952941,"about_ca_system_score_gemma":0.0008012867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00334377,"about_ca_topic_score_gemma":0.001146291,"domain_scores_codex":[0.9959671,0.0009571683,0.002410893,0.0002112237,0.0002174254,0.0002361795],"domain_scores_gemma":[0.9949074,0.0006150763,0.003627577,0.0003533704,0.0004008927,0.00009572491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000118137,0.0002128083,0.8183212,0.002479397,0.002295398,0.00001907001,0.00002142963,3.02305e-7,0.000004578319,0.00002884246,0.001493668,0.1750051],"study_design_scores_gemma":[0.002950654,0.01288465,0.2732131,0.0140127,0.007686613,0.002043744,0.000002715247,0.00001123926,0.00003157276,0.0001799068,0.6866375,0.0003456066],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2991468,0.6986678,0.00001278275,0.00006403687,0.001290444,0.0005266041,0.0001605312,0.000003722107,0.000127341],"genre_scores_gemma":[0.03677949,0.9628637,0.0000617939,0.00009438079,0.000139713,0.000003494395,0.000011627,0.00002594852,0.00001984356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6851438,"threshold_uncertainty_score":0.6512632,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2521726183","doi":"10.1016/s2468-1253(16)30107-8","title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial","year":2016,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":546,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Liver Centre","funders":"U.S. Food and Drug Administration; Gilead Sciences","keywords":"Tenofovir alafenamide; Tenofovir; Medicine; Double blind; Virology; Chronic hepatitis; Internal medicine; Virus; Human immunodeficiency virus (HIV); Placebo; Viral load; Antiretroviral therapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03931133987802224,"gpt":0.3177370063624477,"spread":0.2784256664844255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004952051,0.0006991185,0.00226423,0.0001933075,0.0005325647,0.00002100958,0.0003539317,0.0002787723,0.0001115827],"category_scores_gemma":[0.0001554108,0.0003344284,0.0005049667,0.000232329,0.00178546,0.0001546591,0.0001271311,0.000321095,0.00003983525],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007654737,"about_ca_system_score_gemma":0.0003915651,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005974561,"about_ca_topic_score_gemma":0.1295599,"domain_scores_codex":[0.9959089,0.0004858778,0.00108624,0.0008432906,0.0003685566,0.00130711],"domain_scores_gemma":[0.9957155,0.001607931,0.0008344536,0.001127273,0.0005243492,0.0001904744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5023755,0.001258571,0.4903567,0.00003723654,0.001743842,0.00002024505,0.0002237939,0.000004284454,0.0001515745,0.00001879512,0.0004801252,0.003329341],"study_design_scores_gemma":[0.7672381,0.05491389,0.1692239,0.00006254466,0.001520943,0.00003614611,0.000009570981,0.0002492535,0.0006161393,0.0000486254,0.005861055,0.0002197936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798743,0.0002345278,0.004758607,0.004202058,0.001749821,0.008485986,0.0005159305,0.00009685901,0.0000818831],"genre_scores_gemma":[0.9885767,0.004180841,0.0001480754,0.0005208569,0.001245904,0.005035816,0.00008660343,0.00007570942,0.0001295487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3211327,"threshold_uncertainty_score":0.9999108,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2297828361","doi":"10.1016/j.jhep.2015.11.035","title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","year":2015,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":541,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Entecavir; Internal medicine; Cirrhosis; Cumulative incidence; Cohort; Hepatitis B virus; Proportional hazards model; Incidence (geometry); Gastroenterology; Hepatitis B; Oncology; Immunology; Virus; Lamivudine","retraction":null,"screen_n_in":null,"score":{"opus":0.03426941584179356,"gpt":0.269811894837046,"spread":0.2355424789952524,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008534262,0.0002276986,0.0008707916,0.0003054289,0.0000678864,0.000007939479,0.0002026196,0.0001337228,0.00001482784],"category_scores_gemma":[0.000352203,0.0001316841,0.0001288706,0.0003452042,0.0003019162,0.00009508979,0.00004566019,0.0006102386,0.00001015587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004080413,"about_ca_system_score_gemma":0.001356333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004380299,"about_ca_topic_score_gemma":0.008120512,"domain_scores_codex":[0.99774,0.0004286718,0.0007518324,0.0001876106,0.0005151816,0.0003766931],"domain_scores_gemma":[0.99828,0.0002194328,0.0006610883,0.0002994351,0.0004282432,0.000111827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008959318,0.0001279279,0.9927627,0.00004004972,0.0002573777,0.001226295,0.001732655,0.00001746461,0.000211997,0.0001321417,0.0009112041,0.001684211],"study_design_scores_gemma":[0.006003668,0.007174141,0.9742261,0.0003798846,0.0001378282,0.001137387,0.0002089851,0.0009061566,0.007118823,0.0002165908,0.002314318,0.0001760927],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936535,0.002732059,0.0002152298,0.00205909,0.0002508302,0.0003712178,0.00001003293,0.00001092784,0.0006971448],"genre_scores_gemma":[0.9953122,0.003404318,0.0007183664,0.0002880018,0.0002066683,0.00001056353,0.000002031855,0.00003307389,0.00002482438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01853662,"threshold_uncertainty_score":0.6621731,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2909795031","doi":"10.1016/s2468-1253(18)30270-x","title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission","year":2019,"lang":"en","type":"review","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":540,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"Imperial College London; Medical Research Council; National Institute for Health and Care Research; World Health Organization","keywords":"Medicine; Viral hepatitis; Hepatology; Commission; Hepatitis C; Public health; Global health; Disease Eradication; Hepatitis B; Environmental health; Immunology; Business; Disease; Internal medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.09863817514651889,"gpt":0.3577774505121741,"spread":0.2591392753656552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001906474,0.001549914,0.01032591,0.0006535769,0.0005514157,0.00004728046,0.00209927,0.001399574,0.0003034624],"category_scores_gemma":[0.0005303308,0.0009958921,0.001368727,0.0004459335,0.002176193,0.0001415463,0.001428026,0.003549127,0.0003999135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005072234,"about_ca_system_score_gemma":0.000546152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001082498,"about_ca_topic_score_gemma":0.01789901,"domain_scores_codex":[0.987161,0.004703288,0.003148306,0.001631478,0.0006469435,0.002709032],"domain_scores_gemma":[0.9919184,0.001413648,0.002851298,0.003042604,0.0005228902,0.0002511867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002187344,0.0005053862,0.8708911,0.00917918,0.002851184,0.0002489334,0.0004853497,0.000004059055,0.00003927325,0.0006410077,0.05664196,0.05632522],"study_design_scores_gemma":[0.004327446,0.003545356,0.02083639,0.002814556,0.004314277,0.006505374,0.00004208913,0.0003737548,0.000004642128,0.0001298782,0.9566067,0.0004995056],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07302186,0.8948613,0.001642582,0.01673272,0.004680072,0.006056225,0.0007640216,0.0004386613,0.001802525],"genre_scores_gemma":[0.1089282,0.8781965,0.0009869206,0.007616751,0.001807882,0.001061888,0.0007668374,0.0002304553,0.0004045522],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8999647,"threshold_uncertainty_score":0.9998968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049234248","doi":"10.1056/nejmoa042957","title":"Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":536,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Adefovir; Medicine; HBeAg; Gastroenterology; Placebo; Liter; Internal medicine; Chronic hepatitis; Hepatitis B virus; Hepatitis B; Lamivudine; Virology; HBsAg; Virus; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02563782569915088,"gpt":0.3026544075810035,"spread":0.2770165818818526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005947163,0.0002666796,0.0008696861,0.0002161679,0.000102349,0.00001002224,0.0001361876,0.00007681264,0.0004281541],"category_scores_gemma":[0.0004710493,0.000149287,0.0001177063,0.0001866665,0.0002421569,0.0001694062,0.00001604971,0.0003986895,0.000009385169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003659066,"about_ca_system_score_gemma":0.0004818396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005305295,"about_ca_topic_score_gemma":0.006308154,"domain_scores_codex":[0.9981036,0.00006476241,0.0006512542,0.0001906828,0.0006375248,0.0003521707],"domain_scores_gemma":[0.9980048,0.0004595957,0.0004426356,0.0002066014,0.0005088642,0.000377495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003474053,0.0001685377,0.4348123,0.0001062305,0.0008167864,0.0003245769,0.002672915,0.00001658994,0.001805736,0.00007445481,0.01520137,0.5405264],"study_design_scores_gemma":[0.2071474,0.03231538,0.5757798,0.003243755,0.0007298616,0.003379097,0.00009303041,0.0001015544,0.005807878,0.0002332054,0.1707873,0.0003817559],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9489463,0.01539234,0.003514183,0.02944908,0.000464231,0.0007202825,0.00001004944,0.00003322975,0.001470285],"genre_scores_gemma":[0.9674531,0.01268803,0.002505297,0.001722476,0.01431562,0.00001271572,0.00000781686,0.0000459443,0.001249038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5401447,"threshold_uncertainty_score":0.6087747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2938013723","doi":"10.1016/s2468-1253(19)30119-0","title":"A global scientific strategy to cure hepatitis B","year":2019,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":495,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Liver Centre; Toronto General Hospital; University of Toronto","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Abbott Diagnostics; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; Sanofi; GlaxoSmithKline; Institute of Infection and Immunity; Australian Academy of Science; Bristol-Myers Squibb","keywords":"Medicine; Hepatitis B virus; Hepatitis B; HBsAg; Malaria; Public health; Virology; Immunology; Human immunodeficiency virus (HIV); cccDNA; Virus; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02411914189982917,"gpt":0.2933648535579098,"spread":0.2692457116580806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005477185,0.0004337176,0.001421216,0.0001901857,0.0002982997,0.00006065049,0.0006344682,0.0002532654,0.0005798934],"category_scores_gemma":[0.00007337045,0.0003393348,0.0002177553,0.000496824,0.000760078,0.00009138767,0.0004488256,0.0005196625,0.002351949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002778923,"about_ca_system_score_gemma":0.0002069104,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001669637,"about_ca_topic_score_gemma":0.05655491,"domain_scores_codex":[0.9959236,0.0003885572,0.0006232436,0.001013579,0.0003892423,0.00166179],"domain_scores_gemma":[0.9977929,0.00009114319,0.0001885288,0.001335764,0.0002775854,0.0003140598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008634479,0.0001305608,0.9242614,0.00005179423,0.0002362049,0.0002008142,0.0001654981,0.00002689616,0.000531566,0.0006873909,0.07176615,0.001078277],"study_design_scores_gemma":[0.003020149,0.003410891,0.9153686,0.00005575781,0.0001600403,0.00143414,0.00005860308,0.0006478936,0.00003844475,0.0005231688,0.07507233,0.0002100545],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767542,0.0002822358,0.0006845564,0.01543635,0.002234843,0.001091191,0.0001608154,0.0002026502,0.003153196],"genre_scores_gemma":[0.9813908,0.0001053351,0.0006247537,0.01617845,0.0005101527,0.0001639665,0.00005570819,0.00003874008,0.000932039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05488528,"threshold_uncertainty_score":0.9999059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012824806","doi":"10.1016/j.jhep.2015.01.002","title":"Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy","year":2015,"lang":"en","type":"review","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":495,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Hepatocellular carcinoma; Medicine; Entecavir; Internal medicine; Cirrhosis; Lamivudine; Gastroenterology; Hepatitis B virus; Hepatitis B; Incidence (geometry); Antiviral therapy; Tenofovir; Oncology; Chronic hepatitis; Virus; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.09386333745329432,"gpt":0.3949268960174689,"spread":0.3010635585641746,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001014742,0.0004251645,0.003794675,0.0006916269,0.00003884078,0.000009514278,0.0001708578,0.0002692388,0.0000117881],"category_scores_gemma":[0.00008137211,0.0002803468,0.000301792,0.0003367184,0.0002678202,0.000100057,0.00006392896,0.001046042,0.000002995392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001061453,"about_ca_system_score_gemma":0.003469193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001127956,"about_ca_topic_score_gemma":0.0006965983,"domain_scores_codex":[0.9965588,0.000729487,0.001588567,0.0003084847,0.0004954642,0.0003191476],"domain_scores_gemma":[0.9964361,0.0001877391,0.002356573,0.0003442256,0.0005382371,0.0001371718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005582158,0.000139549,0.5979192,0.002889442,0.0003036136,0.000203515,0.00008691468,4.403797e-7,0.000002046346,0.00002312625,0.0001119812,0.3982643],"study_design_scores_gemma":[0.007152393,0.008477511,0.179916,0.02057862,0.004322924,0.003657173,0.00002558834,0.001170099,0.00003732026,0.0001714341,0.7737051,0.0007858097],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2250125,0.7738968,0.00007788359,0.00003943254,0.0002012419,0.0006762359,0.00003165857,0.000005231031,0.00005906197],"genre_scores_gemma":[0.2569949,0.7423753,0.0003939834,0.000006280665,0.0001393429,0.00003006492,0.00001773269,0.00003838235,0.000004070902],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7735932,"threshold_uncertainty_score":0.9999649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2938147233","doi":"10.1111/ctr.13563","title":"Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice","year":2019,"lang":"en","type":"article","venue":"Clinical Transplantation","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Vaccination; Measles; Immunology; Rubella; Transplantation; Organ transplantation; Attenuated vaccine; Virology; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05930216062128969,"gpt":0.4112437417405669,"spread":0.3519415811192773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008132455,0.000146078,0.0006499381,0.00004317906,0.00008390246,0.000004338036,0.00009562845,0.00007833303,0.00002193473],"category_scores_gemma":[0.0003774364,0.0001078713,0.0001727892,0.0002355926,0.0002775615,0.0001810405,0.000008734403,0.0002618267,0.000002134901],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001873538,"about_ca_system_score_gemma":0.00008002228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005257485,"about_ca_topic_score_gemma":0.001305186,"domain_scores_codex":[0.9976963,0.0005456377,0.001141429,0.0001882879,0.0003118292,0.0001164581],"domain_scores_gemma":[0.9943681,0.004012878,0.0007376548,0.0002571711,0.0005656969,0.00005849499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001768529,0.0003806514,0.972937,0.0007604149,0.0004224017,0.000002020054,0.006006648,0.00002410019,0.007905085,0.00003868001,0.0001019403,0.009652459],"study_design_scores_gemma":[0.002822984,0.0009514875,0.9848499,0.0006370544,0.00152293,0.00001446468,0.000674953,0.0002875386,0.00786477,0.0002248261,0.00004997938,0.00009916582],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937621,0.0002693268,0.002924692,0.0008072396,0.0001228263,0.0004992849,0.001493622,0.00002469277,0.00009619406],"genre_scores_gemma":[0.9649121,0.03247022,0.001470577,0.0005004118,0.0000524508,0.000009634271,0.0005600441,0.00001546342,0.000009156282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0322009,"threshold_uncertainty_score":0.794778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009509017","doi":"10.1053/j.gastro.2010.10.011","title":"Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B","year":2010,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":461,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; University of Calgary; University of Toronto","funders":"Gilead Sciences; GlaxoSmithKline","keywords":"Tenofovir; Medicine; Chronic hepatitis; Virology; Pharmacology; Human immunodeficiency virus (HIV); Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01489959279487033,"gpt":0.2703754516315861,"spread":0.2554758588367158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009896138,0.0001730424,0.0004947256,0.00007154333,0.00007366585,0.000003952342,0.00005565528,0.00008127929,0.00008747737],"category_scores_gemma":[0.00007184858,0.0001368719,0.00008602873,0.00003497088,0.0002864392,0.00003009852,0.00005838354,0.0001170974,0.00001227537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006960064,"about_ca_system_score_gemma":0.0000464034,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008819057,"about_ca_topic_score_gemma":0.04348962,"domain_scores_codex":[0.9989513,0.00002071096,0.0002943635,0.0002790864,0.00008090516,0.0003736746],"domain_scores_gemma":[0.999372,0.00007467698,0.0001003647,0.0002746902,0.0000759108,0.000102361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001726428,0.0002139394,0.9752322,0.00006655943,0.00023651,0.000009117888,0.0001273837,7.85987e-7,0.01157644,0.0002179188,0.0003276054,0.01026514],"study_design_scores_gemma":[0.007962974,0.00949455,0.976778,0.00002929876,0.0001648571,0.0000603258,0.000004479165,0.0001528369,0.0008535916,0.00009181034,0.004347181,0.00006012446],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958634,0.0001341637,0.001208389,0.001407892,0.0002369041,0.0008670687,0.0001181814,0.00003297936,0.0001310575],"genre_scores_gemma":[0.9962454,0.000521492,0.00259095,0.0001553041,0.0002061168,0.0001320013,0.00003675442,0.00002393642,0.00008800731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04260771,"threshold_uncertainty_score":0.9739642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239743462","doi":"10.1016/s2468-1253(16)30024-3","title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial","year":2016,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":458,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Liver Centre; Toronto General Hospital","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Medicine; HBeAg; Internal medicine; Clinical endpoint; Gastroenterology; Placebo; Hepatitis B virus; Entecavir; Hepatitis B; Randomized controlled trial; Pharmacology; Viral load; Virology; HBsAg; Human immunodeficiency virus (HIV); Lamivudine; Virus; Antiretroviral therapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05185355057010008,"gpt":0.3419290628250715,"spread":0.2900755122549714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007443446,0.0007130225,0.00248234,0.0002146703,0.0005907779,0.00002421217,0.0004055117,0.0003606428,0.0001312777],"category_scores_gemma":[0.0001564973,0.0003750213,0.000793632,0.000223296,0.001762908,0.0001407416,0.0001606283,0.0003614108,0.00007383444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008701016,"about_ca_system_score_gemma":0.000436443,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008761002,"about_ca_topic_score_gemma":0.1221691,"domain_scores_codex":[0.9954803,0.0005894931,0.001253502,0.0008932623,0.000319408,0.001464058],"domain_scores_gemma":[0.9955627,0.001857084,0.0007540268,0.001225314,0.0003929637,0.0002079296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6541549,0.0013398,0.3305179,0.0000522822,0.002508779,0.00007347023,0.0003088633,0.000005156339,0.002354166,0.00006987026,0.001294811,0.00731993],"study_design_scores_gemma":[0.8816202,0.04985364,0.04925364,0.00008476122,0.002167721,0.0002343023,0.0000135803,0.0006702277,0.002499144,0.00008918803,0.01323436,0.0002792304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694621,0.0007963394,0.008253405,0.01027133,0.002908053,0.007545581,0.0004828954,0.0001213416,0.0001589404],"genre_scores_gemma":[0.9782316,0.01288183,0.0001053796,0.0008170945,0.002424071,0.005150536,0.00007844429,0.00007619766,0.0002348627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2812643,"threshold_uncertainty_score":0.9998702,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1820160132","doi":"10.4049/jimmunol.177.1.739","title":"Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B","year":2006,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Swine Health Board","keywords":"IL-2 receptor; Immunology; FOXP3; Immune system; Medicine; Hepatitis B; Peripheral blood mononuclear cell; Regulatory T cell; T cell; Biology; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.005731425484544262,"gpt":0.2315310299655796,"spread":0.2257996044810354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008479062,0.0001360394,0.0002958736,0.0001213749,0.000196941,0.00001491116,0.00009957886,0.00004892153,0.000003614098],"category_scores_gemma":[0.0003716238,0.00006943793,0.00002929882,0.0001234041,0.0006017527,0.0001747176,0.0001252798,0.0003617345,0.000001199447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009191681,"about_ca_system_score_gemma":0.0001261245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008016022,"about_ca_topic_score_gemma":0.0001278758,"domain_scores_codex":[0.9984049,0.00062156,0.0004012562,0.0001079314,0.0002585904,0.0002057915],"domain_scores_gemma":[0.9987314,0.0004087108,0.0004149763,0.0002047524,0.000199774,0.00004034617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00929054,0.00009630519,0.954479,0.00002202149,0.0000888405,0.0001954763,0.00144908,0.00001528182,0.03078141,0.00001631516,0.00003589488,0.003529808],"study_design_scores_gemma":[0.001984165,0.000846784,0.9943148,0.0005269935,0.0001022538,0.0001002604,0.0001163912,0.00001921393,0.0017823,0.00008629277,0.00004336316,0.00007721924],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914867,0.007176828,0.000005859191,0.0009380752,0.00004485009,0.0003248683,0.000003371106,0.000005916328,0.0000135483],"genre_scores_gemma":[0.9986401,0.001096338,0.00009054114,0.00009756513,0.0000272625,0.000003974618,6.085442e-7,0.00001410012,0.00002957615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03983574,"threshold_uncertainty_score":0.2831596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2782856081","doi":"10.1016/j.jhep.2017.11.039","title":"96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection","year":2018,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":423,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; Toronto General Hospital","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Medicine; HBeAg; Internal medicine; Tenofovir; Gastroenterology; Entecavir; Population; Prodrug; Randomized controlled trial; Hepatitis B virus; Pharmacology; Viral load; Virology; Virus; Lamivudine; Human immunodeficiency virus (HIV); HBsAg; Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02766504951418523,"gpt":0.316015812205525,"spread":0.2883507626913398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003350143,0.0002897427,0.001284768,0.0004062113,0.0001674144,0.00001046978,0.0001019923,0.0002161024,0.0001481049],"category_scores_gemma":[0.000425288,0.0002137697,0.0004140259,0.0002157349,0.0004230765,0.0001584599,0.00004109142,0.0001577919,0.00004680396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004106059,"about_ca_system_score_gemma":0.0004045169,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007180299,"about_ca_topic_score_gemma":0.01620071,"domain_scores_codex":[0.9977518,0.0001349237,0.001127974,0.0002498306,0.0002886853,0.0004468254],"domain_scores_gemma":[0.9973878,0.0002492052,0.0008990724,0.0002957525,0.0009856118,0.0001825302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001587959,0.0007466526,0.9641526,0.0001104005,0.0007372982,0.0001338216,0.0005830933,0.000002713513,0.01025824,0.0001404077,0.004146588,0.01740026],"study_design_scores_gemma":[0.008861411,0.04353951,0.743409,0.0002649724,0.001356366,0.002675692,0.00003098205,0.00075042,0.09460689,0.001551067,0.1025469,0.0004067421],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926195,0.0009667779,0.001522523,0.002189874,0.001173655,0.0005626398,0.00004861588,0.00002928557,0.0008871239],"genre_scores_gemma":[0.9884393,0.00707307,0.002691473,0.0004164445,0.0008660527,0.00004495217,0.00000997573,0.00004526163,0.0004134268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2207435,"threshold_uncertainty_score":0.999431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049604384","doi":"10.1002/hep.510310130","title":"Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B","year":2000,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Lamivudine; Medicine; Gastroenterology; Cirrhosis; Internal medicine; Liver transplantation; Liver function; Hepatitis B; Liver disease; Exacerbation; Hepatitis B virus; Immunology; Transplantation; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.04022482712753019,"gpt":0.3180839946223588,"spread":0.2778591674948286,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007732065,0.0002636037,0.0007507919,0.0000880436,0.0001960202,0.00001043264,0.00007842876,0.0001716391,0.002629402],"category_scores_gemma":[0.0001527793,0.0002323921,0.0001713324,0.0001394574,0.000112705,0.00004426286,0.00002543903,0.000099852,0.0005288848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005655693,"about_ca_system_score_gemma":0.000167425,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03069203,"about_ca_topic_score_gemma":0.04954565,"domain_scores_codex":[0.9983181,0.00007304223,0.0004542706,0.0004987384,0.0001183826,0.0005374127],"domain_scores_gemma":[0.9988847,0.0004069899,0.00008484055,0.0003894146,0.0001038591,0.0001302099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002725383,0.0001826031,0.8675399,0.00003272431,0.0004256434,0.0001266001,0.0003571043,0.000002326911,0.00165668,0.0001254156,0.003445774,0.1258327],"study_design_scores_gemma":[0.01251485,0.003758244,0.4306768,0.0002037226,0.0007794175,0.0001695904,0.00002115052,0.01861226,0.01527542,0.0006476176,0.516699,0.0006420279],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899734,0.001915781,0.000100893,0.002843527,0.0002257032,0.0007994805,0.0002732791,0.0002153624,0.003652529],"genre_scores_gemma":[0.9882075,0.004161085,0.003583981,0.000753961,0.0003839509,0.0003509699,0.0003471317,0.00004952922,0.002161873],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5132532,"threshold_uncertainty_score":0.9982823,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158084983","doi":"10.1053/jhep.2001.21554","title":"A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B","year":2001,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"London Health Sciences Centre; Toronto General Hospital","funders":"","keywords":"Lamivudine; Liver transplantation; Medicine; Chronic hepatitis; Internal medicine; Transplantation; Clinical trial; Hepatitis B; Gastroenterology; Intensive care medicine; Virology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.02922756235965648,"gpt":0.3047986015380144,"spread":0.2755710391783579,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001095932,0.0001908901,0.0003906083,0.0003627158,0.0001022017,0.00001537534,0.00004848115,0.0001427605,0.0002368667],"category_scores_gemma":[0.00005389568,0.0001765278,0.0000614655,0.0001967673,0.00007808487,0.00006637569,0.00001115377,0.0001069511,0.00003764269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002527624,"about_ca_system_score_gemma":0.0001470564,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1147328,"about_ca_topic_score_gemma":0.9003944,"domain_scores_codex":[0.9987617,0.00006578383,0.000282062,0.0003170962,0.0001014872,0.0004718406],"domain_scores_gemma":[0.9992695,0.0001058548,0.00004404251,0.0001623888,0.0001504893,0.0002677041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01744353,0.00008950615,0.9656301,0.0001868192,0.0001668743,0.0008968826,0.002424383,0.000002486876,0.00006009658,0.0001342062,0.001063257,0.01190186],"study_design_scores_gemma":[0.06860764,0.005611873,0.6579615,0.0001881491,0.000393285,0.0004035274,0.00004553366,0.02439576,0.0003046413,0.0001211374,0.2414842,0.0004827671],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909847,0.0002731163,0.002460326,0.003880998,0.0002459331,0.001798235,0.0002055137,0.00004938833,0.0001017743],"genre_scores_gemma":[0.9861892,0.006121808,0.001059846,0.005113109,0.0002132572,0.0006945043,0.0003150735,0.00004000673,0.0002531346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7856617,"threshold_uncertainty_score":0.8911623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090126805","doi":"10.1053/jhep.2000.8626","title":"Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants","year":2000,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":416,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of British Columbia","funders":"Ochsner Health; Gilead Sciences","keywords":"Adefovir; Lamivudine; Virology; Hepatitis B; Medicine; Gastroenterology; Chronic hepatitis; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.03143001313681783,"gpt":0.301174544590448,"spread":0.2697445314536301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007925391,0.0001955846,0.0006132123,0.00005842628,0.0001489248,0.00000418904,0.0000904993,0.0001060164,0.0009613741],"category_scores_gemma":[0.00008838392,0.0001220158,0.0001962902,0.0001420031,0.0002677566,0.00002450385,0.00001246687,0.00005499063,0.00009377376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001239425,"about_ca_system_score_gemma":0.00009742228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004904757,"about_ca_topic_score_gemma":0.01017417,"domain_scores_codex":[0.9987702,0.00005182494,0.0003931593,0.0002656398,0.0001523269,0.0003668105],"domain_scores_gemma":[0.9988827,0.0004464922,0.00008275172,0.0004160671,0.0001015504,0.0000705083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001199184,0.0007406714,0.8575794,0.0001053168,0.0006926518,0.0001493614,0.001238595,0.000002206774,0.001470147,0.001256162,0.004939623,0.1306267],"study_design_scores_gemma":[0.004332921,0.004744248,0.2601547,0.00006265474,0.0006488109,0.0001455246,0.00005570732,0.00197083,0.008405659,0.0003981379,0.7188399,0.000240906],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876681,0.004389994,0.00006880982,0.002822685,0.0002122577,0.0009754628,0.0001868932,0.0000596262,0.0036162],"genre_scores_gemma":[0.9821392,0.01363639,0.0004310762,0.0004649562,0.0001340425,0.0003479159,0.00001996968,0.0000290561,0.002797384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7139003,"threshold_uncertainty_score":0.9999519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143584498","doi":"10.1053/j.gastro.2006.04.007","title":"Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B","year":2006,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Lamivudine; Entecavir; Chronic hepatitis; Medicine; Refractory (planetary science); Virology; HBeAg; Gastroenterology; Internal medicine; Hepatitis B virus; Virus; Biology; HBsAg","retraction":null,"screen_n_in":null,"score":{"opus":0.01270391927153827,"gpt":0.2690863911462995,"spread":0.2563824718747613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005259127,0.0002115568,0.0006331453,0.0001191584,0.0000584041,0.00000338792,0.00005756667,0.00007986087,0.00007154781],"category_scores_gemma":[0.0000248825,0.0001829438,0.0002112019,0.00005101232,0.0001908128,0.00003707595,0.00002854038,0.00004318868,0.00002056113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004010595,"about_ca_system_score_gemma":0.00005136171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004251185,"about_ca_topic_score_gemma":0.01660638,"domain_scores_codex":[0.9986804,0.00005050639,0.000396291,0.0002949734,0.0001188655,0.0004589429],"domain_scores_gemma":[0.999317,0.00008119147,0.0001585573,0.0002393155,0.0001429025,0.00006106752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008591693,0.0008038424,0.9791686,0.0000626906,0.0003121926,0.00004380397,0.0001047371,0.000007352151,0.0120659,0.0001548215,0.002669271,0.003747643],"study_design_scores_gemma":[0.006537186,0.02366375,0.9387447,0.00006231304,0.0002929381,0.00008535373,0.000007739025,0.0001290909,0.01027892,0.00009715144,0.02000822,0.00009264772],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994123,0.000681082,0.002221805,0.001080299,0.0002336126,0.0008122594,0.0002742733,0.00004884485,0.00052484],"genre_scores_gemma":[0.9968769,0.0004998512,0.001033831,0.0002036318,0.0004279951,0.0002490678,0.0001838481,0.00002488741,0.0005000207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04042388,"threshold_uncertainty_score":0.9266751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385297223","doi":"10.1016/s2468-1253(23)00197-8","title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","year":2023,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Cilag; Pan American Health Organization; Genentech; National Institutes of Health; National Science and Technology Council; Norgine; AOP Orphan; Ipsen; European Association for the Study of the Liver; Janssen Pharmaceuticals; Angelini Pharma; Shionogi; State Government of Victoria; Swedish Orphan Biovitrum; Novo Nordisk; Astellas Pharma; Eisai; Alexion Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Pfizer; European Centre for Disease Prevention and Control; Boston Scientific Corporation; Stiftung für Leberkrankheiten; Asociación Española para el Estudio del Hígado; Alnylam Pharmaceuticals; National Cancer Institute; Gilead Sciences; National Institute of Allergy and Infectious Diseases; Australian Government; Indivior; World Health Organization; GlaxoSmithKline; Abbott Laboratories; CSL Behring; Allergan; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Canadian Association for the Study of the Liver; Amgen; Intercept Pharmaceuticals; National Science Foundation","keywords":"Cascade; Medicine; Virology; Environmental health; Internal medicine; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.02201717143091481,"gpt":0.2864098978668558,"spread":0.264392726435941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004998524,0.0002720704,0.001471467,0.0002613996,0.00007526128,0.000004247936,0.0002641953,0.0001701684,0.00001796816],"category_scores_gemma":[0.00007472464,0.0002235523,0.0001060128,0.0005253034,0.0006114028,0.00004933796,0.00036753,0.0003695516,0.000007391031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001109077,"about_ca_system_score_gemma":0.00008478423,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0051975,"about_ca_topic_score_gemma":0.04775943,"domain_scores_codex":[0.9971321,0.000536748,0.0007857903,0.0005305628,0.0002844821,0.0007303749],"domain_scores_gemma":[0.9987513,0.0001638457,0.0002759261,0.0005612363,0.0001686295,0.00007900644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001372406,0.0002437916,0.9932075,0.0006070302,0.0002360787,0.0003283824,0.00219106,0.0002976383,0.00009881549,0.00004588182,0.0002759547,0.001095453],"study_design_scores_gemma":[0.00366946,0.006175469,0.9847716,0.000108456,0.0001606868,0.000198757,0.000374791,0.004124979,0.00002895755,0.0001891013,0.0001056415,0.00009208491],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996209,0.001194388,0.0003566485,0.0003333637,0.0002329572,0.001169054,0.0001927646,0.00005587649,0.0002559377],"genre_scores_gemma":[0.9951521,0.004017536,0.000190668,0.0003185019,0.0000803715,0.0001761159,0.0000145686,0.00002236527,0.00002784269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04256193,"threshold_uncertainty_score":0.9696165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247967755","doi":"10.1016/j.gastro.2005.05.053","title":"A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B","year":2005,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Telbivudine; Lamivudine; Medicine; Chronic hepatitis; Hepatitis B; Virology; Hepatitis B Antigens; Internal medicine; Gastroenterology; Hepatitis B virus; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.004753048385411875,"gpt":0.2207776836362154,"spread":0.2160246352508035,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002352783,0.0001766761,0.0005743394,0.0001629411,0.00005900506,0.000007016592,0.00007536045,0.0000671185,0.00003937896],"category_scores_gemma":[0.0001180279,0.0001219466,0.00005551298,0.000139309,0.0005111098,0.00009436024,0.00007795269,0.0001959928,0.000007580339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000143135,"about_ca_system_score_gemma":0.00004175165,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0022841,"about_ca_topic_score_gemma":0.02649862,"domain_scores_codex":[0.9985434,0.0001979142,0.0004187552,0.0002596206,0.0002477067,0.0003326421],"domain_scores_gemma":[0.9992771,0.00009702129,0.0001900333,0.0002089343,0.0001753565,0.00005158109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03158433,0.0003987078,0.965445,0.00002304609,0.0001310385,0.000006648576,0.0003480464,0.0000043778,0.00001156584,0.000309971,0.0001845994,0.001552653],"study_design_scores_gemma":[0.1282575,0.006840053,0.8643395,0.00008046966,0.00006145279,0.000008299507,0.000007154797,0.000179012,0.00004634519,0.00002532398,0.0001001926,0.0000546608],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953416,0.00009273209,0.0001296701,0.002679984,0.00009605241,0.00127899,0.00003949967,0.00001840719,0.0003230661],"genre_scores_gemma":[0.998049,0.0007351277,0.0004353184,0.000483261,0.0001069683,0.00009123755,0.0000465607,0.00001966199,0.00003285014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1011055,"threshold_uncertainty_score":0.9912652,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040562731","doi":"10.1053/j.gastro.2008.05.031","title":"Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b","year":2008,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Foundation for Liver Research","keywords":"HBsAg; Medicine; HBeAg; Lamivudine; Negativity effect; Internal medicine; Gastroenterology; Pegylated interferon; Chronic hepatitis; Hepatitis B; Hepatitis B virus; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.008398572866015114,"gpt":0.2267843579647525,"spread":0.2183857850987374,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000607555,0.0003053561,0.0007228727,0.0001853363,0.00007537886,0.000004857194,0.00007875548,0.000101302,0.00007252982],"category_scores_gemma":[0.00004681369,0.0002406236,0.00009183683,0.00009279357,0.000653712,0.00009258555,0.0001689799,0.0001871207,0.00001206129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001019515,"about_ca_system_score_gemma":0.00003189871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002492526,"about_ca_topic_score_gemma":0.001584569,"domain_scores_codex":[0.9982858,0.0001139672,0.0003883034,0.0004252643,0.0002140843,0.0005725416],"domain_scores_gemma":[0.9989939,0.00004200551,0.000164606,0.0002872828,0.0003402796,0.0001719247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01392492,0.0003404817,0.982733,0.00008562477,0.0004456928,0.000788073,0.001003487,2.56282e-7,0.0001644966,0.000002053587,0.0002781097,0.000233798],"study_design_scores_gemma":[0.01011707,0.009996815,0.9785217,0.0001531155,0.0002331612,0.0003478577,0.00003642862,0.000005581299,0.0004707668,0.000002117112,0.00001138294,0.0001040259],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984588,0.00008321435,0.0001755417,0.0003136041,0.00009756215,0.0005744843,0.0000720848,0.00004418086,0.0001805309],"genre_scores_gemma":[0.9984496,0.0001205683,0.0001132662,0.0005864119,0.00005281308,0.00006906503,0.00008555032,0.0000404741,0.0004823027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009656332,"threshold_uncertainty_score":0.9812344,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1964242359","doi":"10.1053/j.gastro.2003.10.050","title":"Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus","year":2003,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Adefovir; Lamivudine; Medicine; Gastroenterology; Hepatitis B virus; Internal medicine; Hepatitis B; Virology; Liver function; Chronic hepatitis; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.0119190107964072,"gpt":0.250458555006888,"spread":0.2385395442104808,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002812681,0.000411745,0.0009004883,0.000410315,0.000107215,0.00001803076,0.0001551468,0.0001288493,0.000529832],"category_scores_gemma":[0.0002997528,0.0003673501,0.0001009792,0.0004129706,0.0001941458,0.0001082259,0.0001150141,0.0004281236,0.0002515358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008565546,"about_ca_system_score_gemma":0.0002005398,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01432199,"about_ca_topic_score_gemma":0.4916104,"domain_scores_codex":[0.9969294,0.0002448754,0.0006190559,0.0006909505,0.0003484096,0.001167323],"domain_scores_gemma":[0.9988279,0.00007163317,0.0001367121,0.0005225496,0.0001262536,0.000314986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005586641,0.0001856893,0.9865922,0.00006328324,0.0001556359,0.0009836105,0.0004500017,0.0000760988,0.009041118,0.0001392027,0.0009941431,0.0007603695],"study_design_scores_gemma":[0.004631546,0.007123099,0.9747055,0.0003337887,0.00009520735,0.0006540146,0.00002609782,0.0001347111,0.003834578,0.00003178942,0.008183496,0.0002461361],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946327,0.0002313056,0.001136658,0.00149509,0.0002448572,0.0008343527,0.00006321503,0.0001189116,0.001242917],"genre_scores_gemma":[0.9923578,0.0008419649,0.002366731,0.003625107,0.000153469,0.000305205,0.00003049908,0.00007565143,0.0002435915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4772884,"threshold_uncertainty_score":0.9998779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2507136820","doi":"10.1016/j.jhep.2016.08.009","title":"The role of quantitative hepatitis B surface antigen revisited","year":2016,"lang":"en","type":"review","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"HBsAg; Medicine; HBeAg; Hepatitis B; Immunology; Hepatitis B virus; Pegylated interferon; Virology; Antigen; cccDNA; Chronic hepatitis; Virus; Ribavirin","retraction":null,"screen_n_in":null,"score":{"opus":0.04548051252086148,"gpt":0.3747517444823678,"spread":0.3292712319615063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048516,0.0003777426,0.004188901,0.0002486051,0.0001292117,0.0000109247,0.0003881271,0.0003406117,0.00009718156],"category_scores_gemma":[0.001825008,0.0001859489,0.0009965901,0.0003196498,0.0004420236,0.00007280456,0.0001265739,0.0006157745,0.0001066847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001912529,"about_ca_system_score_gemma":0.0009687833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001954801,"about_ca_topic_score_gemma":0.0001820854,"domain_scores_codex":[0.9960248,0.0007778748,0.002139284,0.0002174315,0.0004497384,0.0003908607],"domain_scores_gemma":[0.9931734,0.002136693,0.003092802,0.0004393788,0.001021648,0.0001361424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001450099,0.0001048403,0.09440399,0.00442326,0.00341902,0.0004282233,0.0001863271,4.617696e-8,0.00003187684,0.002101182,0.007158543,0.8875977],"study_design_scores_gemma":[0.0003334004,0.0007269938,0.0004064866,0.01578246,0.001078513,0.00173498,0.00002322269,0.000001975695,0.00003540694,0.0003732995,0.9793431,0.000160117],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008908992,0.9961745,0.00004672243,0.0003726293,0.000475931,0.000453511,0.00007133255,0.000009876886,0.001504655],"genre_scores_gemma":[0.0009198071,0.9976077,0.0009803709,0.00004714983,0.0001873131,0.000005232092,0.000005413002,0.00005496057,0.000192068],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9721846,"threshold_uncertainty_score":0.7582778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143216061","doi":"10.1016/j.cgh.2006.05.016","title":"A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update","year":2006,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Stanford Bio-X; Gilead Sciences; GlaxoSmithKline; Valeant Pharmaceuticals International; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Entecavir; Lamivudine; Adefovir; Cirrhosis; Algorithm; Internal medicine; Hepatitis B virus; Hepatitis B; Gastroenterology; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.08454799308810558,"gpt":0.4140784256636249,"spread":0.3295304325755193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007485329,0.0004015956,0.002247746,0.0002093018,0.0001304825,0.000008568633,0.0001910152,0.0004046649,0.00001559545],"category_scores_gemma":[0.0000237382,0.0002142438,0.0004554877,0.0001852034,0.0008075906,0.00002553196,0.0001035829,0.000482119,0.000007542676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001574045,"about_ca_system_score_gemma":0.00009027686,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.009420614,"about_ca_topic_score_gemma":0.06607918,"domain_scores_codex":[0.9963669,0.001087734,0.001425871,0.0005384333,0.00009789508,0.0004832023],"domain_scores_gemma":[0.997851,0.0009799937,0.0005025038,0.0005298083,0.00007043243,0.00006633058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001631914,0.0009367292,0.1884471,0.002205964,0.001482127,0.0001857928,0.00004083153,0.000001678069,3.064245e-9,0.0001140716,0.0005033265,0.8059192],"study_design_scores_gemma":[0.002977972,0.01098132,0.0441326,0.0009317621,0.005133898,0.0004513978,0.00001112345,0.00235639,5.239906e-8,0.00009010507,0.9328058,0.0001275315],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03611572,0.9529688,0.004772611,0.0009203178,0.0006606183,0.004131433,0.0003677795,0.00003980894,0.00002289068],"genre_scores_gemma":[0.0008089406,0.9953059,0.0005282565,0.0008764906,0.0002110087,0.00124595,0.0009641407,0.00003180327,0.00002748608],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9323025,"threshold_uncertainty_score":0.9971758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169342982","doi":"10.1016/j.hep.2003.09.040","title":"Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre- and Post-Liver Transplantation Patients","year":2003,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Lamivudine; Adefovir; Liver transplantation; Medicine; Gastroenterology; Internal medicine; Hepatitis B; Transplantation; Virology; Chronic hepatitis; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01498917477126441,"gpt":0.2649346854859283,"spread":0.2499455107146639,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001264267,0.0001769288,0.0004022243,0.000144761,0.0000788524,0.000006708212,0.00003783626,0.0001353475,0.00006275879],"category_scores_gemma":[0.000193917,0.0001574885,0.00005483138,0.0001139313,0.000104486,0.00007389019,0.00000872799,0.0001075524,0.000008949246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007030911,"about_ca_system_score_gemma":0.00007068687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002736352,"about_ca_topic_score_gemma":0.01089955,"domain_scores_codex":[0.9987999,0.0001150512,0.0003164989,0.0003181565,0.0001269012,0.0003235459],"domain_scores_gemma":[0.9993887,0.0001814098,0.0000681784,0.0001424468,0.0001472607,0.00007198726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008423962,0.0001875265,0.98991,0.0001861118,0.00004795838,0.00008689571,0.001299505,1.495856e-7,0.0009568693,0.001676691,0.0002148363,0.004591079],"study_design_scores_gemma":[0.004829201,0.001110784,0.9852255,0.00004839983,0.00004799257,0.00005002398,0.00001269773,0.0001083547,0.001568147,0.0001794621,0.006661469,0.0001579753],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995739,0.001449323,0.000124603,0.0003101124,0.0001479221,0.001064363,0.0001116601,0.00003665977,0.001016348],"genre_scores_gemma":[0.9877019,0.01002442,0.000747756,0.001033704,0.00001943436,0.0002426277,0.00007978306,0.00002736174,0.0001230344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0085751,"threshold_uncertainty_score":0.6422195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966525043","doi":"10.1053/j.gastro.2009.06.054","title":"Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection","year":2009,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"UCLH Biomedical Research Centre; Medical Research Council; Wellcome Trust","keywords":"Viremia; Immunology; Immune system; Hepatitis B virus; Viral load; Interferon; Cytokine; Medicine; Virology; Biology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.008430389753146231,"gpt":0.256662648944417,"spread":0.2482322591912708,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120733,0.0001421982,0.0006478166,0.0007400929,0.00002912094,0.000003917361,0.00004897493,0.00006224988,0.00005074192],"category_scores_gemma":[0.00004865863,0.0001202096,0.0001093743,0.0005280564,0.0000996333,0.00007783591,0.00002766068,0.0001419731,0.000004724914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007673063,"about_ca_system_score_gemma":0.00002152636,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01353372,"about_ca_topic_score_gemma":0.03691141,"domain_scores_codex":[0.9987779,0.0001246786,0.0004015266,0.0002204782,0.0001849205,0.0002905484],"domain_scores_gemma":[0.9993778,0.00002243674,0.0001689443,0.0002434598,0.0001351183,0.00005228096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007011143,0.0003973113,0.9901475,0.000004185474,0.001159499,0.00004878791,0.000213499,0.00001348211,0.0004802971,0.000003044931,0.00003557824,0.0004856145],"study_design_scores_gemma":[0.002419254,0.009084206,0.9873508,0.00002523556,0.000871602,0.000004936262,0.000001543733,0.00002947352,0.0001408444,0.000006465519,0.00001598466,0.00004966627],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990763,0.00001728956,0.0002424223,0.0002428568,0.00004779468,0.0002380236,0.00005264737,0.00002755273,0.0000550775],"genre_scores_gemma":[0.9989834,0.0001108482,0.0003946381,0.0003594201,0.00001231559,0.00001339852,0.00007831966,0.000008771274,0.00003886735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02337769,"threshold_uncertainty_score":0.9930353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2984221112","doi":"10.1016/j.jhep.2019.11.003","title":"Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡","year":2019,"lang":"en","type":"review","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":358,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Barts and The London School of Medicine and Dentistry; Perelman School of Medicine, University of Pennsylvania; Universitätsklinikum Hamburg-Eppendorf; National Institutes of Health; European Association for the Study of the Liver; National and Kapodistrian University of Athens; Università degli Studi di Parma; University of Toronto; University College London; National Institute for Health and Care Research; Universitätsklinikum Essen; Università degli Studi di Milano; University of Pennsylvania; Barts Charity; Universität Duisburg-Essen; Roche; Gilead Sciences; Deutsches Zentrum für Infektionsforschung; Universität Hamburg; Bristol-Myers Squibb","keywords":"Medicine; HBsAg; Clinical endpoint; Clinical trial; Internal medicine; Surrogate endpoint; Hepatitis B; Discontinuation; HBeAg; Chronic hepatitis; cccDNA; Hepatitis B virus; Gastroenterology; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.5009424665261447,"gpt":0.5366977400755869,"spread":0.03575527354944219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01185816,0.000570751,0.01257612,0.0002835875,0.00005202937,0.00001765179,0.0003347351,0.0007378031,0.0001419938],"category_scores_gemma":[0.01531479,0.0003198432,0.001788246,0.0001461518,0.0003567927,0.00008126139,0.0001099614,0.0007523632,0.0000212031],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006154338,"about_ca_system_score_gemma":0.005637925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002720302,"about_ca_topic_score_gemma":0.003067793,"domain_scores_codex":[0.9856688,0.004634371,0.008294449,0.0005605262,0.0003976562,0.0004442251],"domain_scores_gemma":[0.9718481,0.018262,0.008486537,0.0007219198,0.0005024833,0.0001789644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009281365,0.0004293074,0.1236594,0.004079777,0.004767672,0.002030949,0.0002315105,0.000001049464,0.0000125115,0.00009143031,0.0186714,0.8450969],"study_design_scores_gemma":[0.00627624,0.004689578,0.006389466,0.01951056,0.007335592,0.003756508,0.00001088421,0.00005844772,0.00005095369,0.0003320196,0.9512399,0.0003498169],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002261522,0.99093,0.0009156597,0.0005745024,0.001576109,0.003284201,0.0003199452,0.000007038849,0.0001310439],"genre_scores_gemma":[0.001665373,0.9922609,0.004455465,0.0001056911,0.0009304236,0.0001192824,0.00006455676,0.00005848861,0.0003398562],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9325686,"threshold_uncertainty_score":0.9999992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2173007581","doi":"10.1053/j.gastro.2015.09.043","title":"Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B","year":2015,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto General Hospital; Toronto Liver Centre","funders":"","keywords":"HBsAg; Medicine; Discontinuation; Gastroenterology; Internal medicine; Hepatitis B virus; Adverse effect; Hepatitis B; Group B; Randomized controlled trial; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.00973399380651255,"gpt":0.2293274492372129,"spread":0.2195934554307004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001872716,0.0001933217,0.0006566067,0.000160016,0.00002223846,0.000004089386,0.00008109566,0.00006977947,0.00001966544],"category_scores_gemma":[0.00009421014,0.0001672249,0.00003510909,0.0001228745,0.0004120672,0.0001250485,0.0001218622,0.0001256041,0.000003788381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001609437,"about_ca_system_score_gemma":0.00007592193,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02084314,"about_ca_topic_score_gemma":0.04550831,"domain_scores_codex":[0.9985226,0.0001565868,0.0004550604,0.0002777592,0.0002567861,0.0003312042],"domain_scores_gemma":[0.9990358,0.00003821277,0.0002604332,0.0002317724,0.0003196162,0.0001141198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001625775,0.0005587143,0.9965559,0.0001435726,0.0001072023,0.00002046305,0.0003381117,0.00001903273,0.0001397969,0.00002159601,0.0001278039,0.0003419955],"study_design_scores_gemma":[0.007014089,0.01058027,0.9814975,0.0002210928,0.00005124661,0.00001690161,0.00001690388,0.0001856271,0.0002882103,0.00003193823,0.00002124001,0.00007492624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986255,0.0002333374,0.0001826913,0.0002235258,0.00007217551,0.0004988932,0.00008898288,0.00001776036,0.00005710315],"genre_scores_gemma":[0.9990255,0.0004571702,0.0002771033,0.00007863066,0.00001578326,0.00001609161,0.00008545876,0.00002314307,0.00002108736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02466517,"threshold_uncertainty_score":0.9856771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116148860","doi":"10.1016/j.jhep.2005.10.018","title":"Virologic response and resistance to adefovir in patients with chronic hepatitis B","year":2005,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Association for the Study of the Liver; Gilead Sciences; GlaxoSmithKline; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Adefovir; Lamivudine; Medicine; Gastroenterology; Hepatitis B; Hepatitis B virus; Chronic hepatitis; Internal medicine; Virology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.008300306738565353,"gpt":0.2532279282029309,"spread":0.2449276214643656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004110298,0.0001348866,0.000548684,0.0003260209,0.00004371047,0.000005780187,0.0000757225,0.00008948677,0.00004875197],"category_scores_gemma":[0.0005063917,0.00009811019,0.0000373624,0.0001941121,0.0001165761,0.0001024813,0.0000448228,0.000275574,0.00002005541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003825774,"about_ca_system_score_gemma":0.0002040081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001036379,"about_ca_topic_score_gemma":0.01548148,"domain_scores_codex":[0.9986512,0.000188878,0.0004809517,0.0001631385,0.0002343912,0.000281434],"domain_scores_gemma":[0.9991321,0.0001800615,0.0002051244,0.0001479416,0.0001883888,0.0001464022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007329911,0.0001303419,0.9881609,0.00002143653,0.00004722034,0.0002741446,0.0002661856,0.000005976479,0.0002171633,0.00002446157,0.001657275,0.001864958],"study_design_scores_gemma":[0.003139033,0.003343207,0.9739062,0.0001359374,0.00003671179,0.000158652,0.000004957245,0.000008094408,0.0001839999,0.00003169126,0.01895763,0.00009388538],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882401,0.001583742,0.00003094391,0.009649756,0.00007038413,0.0002121275,0.000004400727,0.000008201409,0.0002003952],"genre_scores_gemma":[0.9938991,0.0003449916,0.00382507,0.001695187,0.00008743533,0.000006941802,6.530863e-7,0.0000147322,0.0001258644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01730035,"threshold_uncertainty_score":0.863903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140430530","doi":"10.4049/jimmunol.1103139","title":"IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection","year":2012,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":334,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"CD38; Hepatitis B virus; Regulatory B cells; Ex vivo; CD19; Biology; Immunology; Immune system; Pathogenesis; T cell; CD8; B cell; Hepatitis B; Virus; CD24; Virology; In vivo; Interleukin 10; Cell; Antibody; Stem cell; CD34","retraction":null,"screen_n_in":null,"score":{"opus":0.01761288990991625,"gpt":0.2589902613969207,"spread":0.2413773714870045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00207739,0.0001093208,0.0003683463,0.0001681368,0.00008372926,0.000002692975,0.0001522703,0.00007953976,0.0001193269],"category_scores_gemma":[0.0002742707,0.00006050733,0.0001014536,0.0002190986,0.0002151989,0.0001114099,0.00005767468,0.0003469335,0.00002956984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002008383,"about_ca_system_score_gemma":0.000114645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003956623,"about_ca_topic_score_gemma":0.0021317,"domain_scores_codex":[0.9983906,0.0005439242,0.0005341038,0.00005969375,0.0002120748,0.0002596772],"domain_scores_gemma":[0.9987468,0.0002696566,0.0004558841,0.0003395551,0.0001649408,0.0000232162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002295557,0.0002672269,0.2449593,0.00005062177,0.0002690636,0.00001451906,0.005810864,0.00003770362,0.7355683,0.00004661736,0.001133512,0.01161278],"study_design_scores_gemma":[0.0005136942,0.000737985,0.9182444,0.000111545,0.0001732273,0.000524027,0.0001071917,0.000005372784,0.07547411,0.00003307084,0.004021444,0.00005397664],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843951,0.01402828,0.00005028491,0.0005838563,0.0006011269,0.0001542927,0.000003662824,0.000005346301,0.0001779785],"genre_scores_gemma":[0.9820093,0.01727725,0.00005172629,0.0001577426,0.0004101766,0.000003799121,5.633862e-7,0.00001334539,0.00007611263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6732851,"threshold_uncertainty_score":0.5981258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137059754","doi":"10.1007/s10875-004-6244-3","title":"CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Immunology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Ottawa Hospital; Toronto Western Hospital; University of Ottawa","funders":"","keywords":"Medicine; HBsAg; Adjuvant; Immunogenicity; Tolerability; Immunology; CpG Oligodeoxynucleotide; Immune system; Adverse effect; Internal medicine; Hepatitis B virus; Biology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.09171082531330603,"gpt":0.4688525420434794,"spread":0.3771417167301734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003214817,0.0004856178,0.00288298,0.0007511844,0.0002694916,0.0000317424,0.0005929345,0.0004417632,0.0002456114],"category_scores_gemma":[0.003496472,0.0004031908,0.0004751066,0.0006411714,0.0002368078,0.0003628274,0.0003835276,0.002233357,0.0001882422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004229448,"about_ca_system_score_gemma":0.001349205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002589156,"about_ca_topic_score_gemma":0.00521458,"domain_scores_codex":[0.9922811,0.0006126281,0.00499211,0.0006412414,0.000628096,0.0008447749],"domain_scores_gemma":[0.9953885,0.0006711041,0.001379755,0.0009313439,0.0009580577,0.0006712017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6975518,0.06029449,0.1622902,0.00008821284,0.003463655,0.006979504,0.009262728,0.0002140786,0.002510462,0.0002392208,0.0004932953,0.05661229],"study_design_scores_gemma":[0.3183296,0.2420169,0.4263769,0.0007900336,0.0005861046,0.0009323655,0.001919671,0.00001840249,0.0003048314,0.0002406815,0.007992065,0.0004924569],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844184,0.003377449,0.00006117625,0.00851062,0.001810813,0.001582978,0.0000107954,0.00005255091,0.0001752362],"genre_scores_gemma":[0.9918538,0.002151455,0.001146665,0.003759702,0.0008825542,0.00005185002,0.000009183393,0.00007702771,0.00006770132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3792223,"threshold_uncertainty_score":0.999842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2886930165","doi":"10.1172/jci121960","title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":326,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; National Institute for Health and Care Research; Gilead Sciences; Wellcome Trust; F. Hoffmann-La Roche; Roche","keywords":"HBsAg; Hepatitis B virus; Antibody; Immunology; Hepatitis B; Antigen; Biology; Virology; B cell; Medicine; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.080721254435213,"gpt":0.3812247071006864,"spread":0.3005034526654734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001556523,0.0001048615,0.0005909334,0.0001492018,0.00005501505,0.00001818235,0.0000426574,0.0001202528,0.00001300167],"category_scores_gemma":[0.005486742,0.00008732834,0.0001006178,0.0002146819,0.000472482,0.0002223268,0.00003270562,0.0004367829,0.00001302662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006058034,"about_ca_system_score_gemma":0.0001437326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002557303,"about_ca_topic_score_gemma":0.00109262,"domain_scores_codex":[0.997887,0.00026721,0.001275838,0.0001511755,0.0002708077,0.0001480067],"domain_scores_gemma":[0.9978036,0.000633526,0.0008699815,0.00009428548,0.0004385982,0.0001599895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005781823,0.00005691344,0.988928,0.00004351352,0.00005059468,0.0001108157,0.0006356874,0.000001201508,0.001959947,0.00004414757,0.0002903831,0.007820957],"study_design_scores_gemma":[0.001214866,0.0009666527,0.9893174,0.0007795283,0.00008362821,0.0000609587,0.00006478053,0.001552366,0.003099798,0.002684653,0.00009476828,0.00008056422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978187,0.0001129263,0.0001892723,0.000875926,0.0004283348,0.0001529401,0.000001736158,0.000008794363,0.0004113881],"genre_scores_gemma":[0.9938402,0.0003440232,0.004017639,0.0009131196,0.0008548931,0.000001684698,7.801182e-7,0.00001216734,0.00001549821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007740393,"threshold_uncertainty_score":0.6568539,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995612767","doi":"10.1002/hep.23952","title":"Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease","year":2010,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":323,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Stornoway Diamond (Canada); Toronto General Hospital","funders":"","keywords":"Entecavir; Tenofovir; Emtricitabine; Medicine; Chronic hepatitis; Hepatitis B; Virology; Internal medicine; Gastroenterology; Lamivudine; Virus; Human immunodeficiency virus (HIV)","retraction":null,"screen_n_in":null,"score":{"opus":0.005681092652679826,"gpt":0.2219883077661795,"spread":0.2163072151134997,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001223482,0.0003561128,0.0006975902,0.0002939547,0.0001366848,0.00001883149,0.0001187162,0.000177984,0.0002946472],"category_scores_gemma":[0.0002456161,0.000286197,0.000057526,0.0003505792,0.0004431187,0.0001509637,0.0001644396,0.0005421478,0.0001404649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001964312,"about_ca_system_score_gemma":0.000334747,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004444441,"about_ca_topic_score_gemma":0.0589268,"domain_scores_codex":[0.997917,0.0001040812,0.0004342107,0.0006164896,0.0002785334,0.0006496797],"domain_scores_gemma":[0.9987308,0.0001172111,0.0001333509,0.0004713501,0.0001968236,0.000350449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005179278,0.0003966329,0.9913499,0.0001307732,0.00007558531,0.0005370571,0.0001789516,3.817711e-7,0.0001573234,0.0001812091,0.0003782031,0.006096009],"study_design_scores_gemma":[0.00428187,0.0007158025,0.9888659,0.00008417068,0.0001167699,0.00003683495,0.000003089011,0.001204744,0.00008291806,0.0000782572,0.004220069,0.0003095786],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965296,0.0008797743,0.00002284505,0.0007924974,0.0002611241,0.0009579947,0.00006273072,0.0001051862,0.000388251],"genre_scores_gemma":[0.9979258,0.0006572478,0.0002526944,0.0005591203,0.0000772666,0.0001446868,0.0001052683,0.00004847528,0.0002294489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05448236,"threshold_uncertainty_score":0.999959,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}